专题:Prostate Cancer Diagnosis and Treatment

This cluster of papers encompasses a wide range of research on prostate cancer, including screening methods, treatment options such as radiation therapy and surgery, use of MRI imaging for detection, genetic factors, and clinical guidelines for management. The papers also cover topics like Gleason grading, androgen suppression, biopsy techniques, and long-term survival rates.
最新文献
The Number of Cancer-Involved Regions in Patients With Prostate Cancer Diagnosed by Magnetic Resonance Imaging/Ultrasound-Guided Fusion Prostate Biopsy Is a New Tumor Metric Associated With the Increased Risk of Adverse Pathology at Radical Prostatectomy

article Full Text OpenAlex

Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study

article Full Text OpenAlex

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration

article Full Text OpenAlex

Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation

article Full Text OpenAlex

Safety and Efficacy of Vibegron in Men With Overactive Bladder Symptoms on Pharmacotherapy for Benign Prostatic Hyperplasia: Results From the 28-Week Open-Label COURAGE Extension Trial Completing the 52-Week Phase 3 Evaluation

article Full Text OpenAlex

A randomized phase III trial of structured tumour response surveillance and shared decision‐making for organ preservation in rectal cancer – PRODIGE 101‐ GRECCAR 20‐ EVAREC trial protocol

article Full Text OpenAlex

Radioterapia pélvica electiva en el cáncer de próstata: el ocaso de una práctica histórica

article Full Text OpenAlex

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial

article Full Text OpenAlex

Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies

article Full Text OpenAlex

Long-term Functional Outcomes and Decision Regret after Robot-assisted Radical Prostatectomy: An Experienced Surgeon Series

article Full Text OpenAlex

近5年高被引文献
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

review Full Text OpenAlex 875 FWCI375.7797

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

article Full Text OpenAlex 839 FWCI120.2235

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

review Full Text OpenAlex 793 FWCI113.232

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

article Full Text OpenAlex 727 FWCI103.9607

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

article Full Text OpenAlex 678 FWCI178.4023

Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019

article Full Text OpenAlex 613 FWCI91.3456

The Lancet Commission on prostate cancer: planning for the surge in cases

review Full Text OpenAlex 537 FWCI231.3295

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 522 FWCI136.3877

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

article Full Text OpenAlex 448 FWCI63.555

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

article Full Text OpenAlex 401 FWCI56.865